A preliminary study: the anti-proliferation effect of salidroside on different human cancer cell lines
Authors:
- 23 March 2010
- journal article
- research article
- Published by Springer Nature in Cell Biology and Toxicology
- Vol. 26 (6) , 499-507
Abstract
Salidroside (p-hydroxyphenethyl-beta-d-glucoside), which is present in all species of the genus Rhodiola, has been reported to have a broad spectrum of pharmacological properties. The present study, for the first time, focused on evaluating the effects of the purified salidroside on the proliferation of various human cancer cell lines derived from different tissues, and further investigating its possible molecular mechanisms. Cell viability assay and [3H] thymidine incorporation were used to evaluate the cytotoxic effects of salidroside on cancer cell lines, and flow cytometry analyzed the change of cell cycle distribution induced by salidroside. Western immunoblotting further studied the expression changes of cyclins (cyclin D1 and cyclin B1), cyclin-dependent kinases (CDK4 and Cdc2), and cyclin-dependent kinase inhibitors (p21Cip1 and p27Kip1). The results showed that salidroside inhibited the growth of various human cancer cell lines in concentration- and time-dependent manners, and the sensitivity to salidroside was different in those cancer cell lines. Salidroside could cause G1-phase or G2-phase arrest in different cancer cell lines, meanwhile, salidroside resulted in a decrease of CDK4, cyclin D1, cyclin B1 and Cdc2, and upregulated the levels of p27Kip1 and p21Cip1. Taken together, salidroside could inhibit the growth of cancer cells by modulating CDK4-cyclin D1 pathway for G1-phase arrest and/or modulating the Cdc2-cyclin B1 pathway for G2-phase arrest.Keywords
This publication has 24 references indexed in Scilit:
- Chinese medicinal herb Scutellaria barbata modulates apoptosis and cell survival in murine and human prostate cancer cells and tumor development in TRAMP miceEuropean Journal Of Cancer Prevention, 2009
- Anti‐inflammatory activity of Rhodiola rosea – “a second‐generation adaptogen”Phytotherapy Research, 2009
- Decreased mitochondrial superoxide levels and enhanced protection against paraquat inDrosophilamelanogastersupplemented withRhodiola roseaFree Radical Research, 2009
- Aqueous extract of Rhodiola imbricata rhizome inhibits proliferation of an erythroleukemic cell line K-562 by inducing apoptosis and cell cycle arrest at G2/M phaseImmunobiology, 2008
- CDK Inhibitors: Cell Cycle Regulators and BeyondDevelopmental Cell, 2008
- In vivo Significance of the G2 Restriction PointCancer Research, 2007
- Digoxin-Like Immunoreactive Factors Induce Apoptosis in Human Acute T-Cell Lymphoblastic LeukemiaClinical Chemistry, 2007
- Radioprotection by Rhodiola imbricata in Mice Against Whole-Body Lethal IrradiationJournal of Medicinal Food, 2006
- Effect of a combination of extract from several plants on Cell‐mediated and humoral immunity of patients with advanced ovarian cancerPhytotherapy Research, 2006
- Thymoquinone: A promising anti-cancer drug from natural sourcesThe International Journal of Biochemistry & Cell Biology, 2006